Amarin Corp Plcuk (AMRN) Interest & Investment Income (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Interest & Investment Income of $2.4 million for Q1 2026, down 15.63% YoY from $2.9 million in Q1 2025, and down 5.94% sequentially from $2.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Interest & Investment Income (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Interest & Investment Income across 17 years of filings, most recently posting $2.4 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 15.63% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 19.31% YoY), while the FY2025 annual figure was $10.9 million, down 19.03% from the prior year.
  • Interest & Investment Income fell to $2.4 million in Q1 2026, from $2.6 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for AMRN reached as high as $3.4 million in Q4 2023 and fell as low as $203000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $2.8 million (2025), against an average of $2.4 million.
  • Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 56.9% — and 2023, when it soared 994.09%.
  • A 5-year view of Interest & Investment Income shows it stood at $1.6 million in 2022, then jumped by 117.05% to $3.4 million in 2023, then retreated by 1.46% to $3.4 million in 2024, then dropped by 23.67% to $2.6 million in 2025, then declined by 5.94% to $2.4 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $2.4 million, $2.6 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 229.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -645.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 73.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 2.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.42 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.78 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 2.87 Mn
Dec 31, 2024 3.38 Mn
Sep 30, 2024 3.37 Mn
Jun 30, 2024 3.27 Mn
Mar 31, 2024 3.38 Mn
Dec 31, 2023 3.43 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 3.00 Mn
Mar 31, 2023 2.22 Mn
Dec 31, 2022 1.58 Mn
Sep 30, 2022 750,000.00
Jun 30, 2022 288,000.00
Mar 31, 2022 203,000.00
Dec 31, 2021 301,000.00
Sep 30, 2021 163,000.00
Jun 30, 2021 285,000.00